Silva Pharmaceuticals Limited (DSE:SILVAPHL)

Silva Pharmaceuticals Statistics

Total Valuation

DSE:SILVAPHL has a market cap or net worth of BDT 1.49 billion. The enterprise value is 1.41 billion.

Market Cap	1.49B
Enterprise Value	1.41B

Important Dates

The last earnings date was Tuesday, April 28, 2026.

Earnings Date	Apr 28, 2026
Ex-Dividend Date	n/a

Share Statistics

DSE:SILVAPHL has 136.50 million shares outstanding.

Current Share Class	136.50M
Shares Outstanding	136.50M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	25.05%
Owned by Institutions (%)	n/a
Float	64.35M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	4.51
PB Ratio	0.74
P/TBV Ratio	0.74
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-9.12
EV / Sales	4.27
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-100.96

Financial Position

The company has a current ratio of 21.19, with a Debt / Equity ratio of 0.00.

Current Ratio	21.19
Quick Ratio	7.88
Debt / Equity	0.00
Debt / EBITDA	n/a
Debt / FCF	-0.18
Interest Coverage	-38.01

Financial Efficiency

Return on equity (ROE) is -7.37% and return on invested capital (ROIC) is -7.28%.

Return on Equity (ROE)	-7.37%
Return on Assets (ROA)	-3.98%
Return on Invested Capital (ROIC)	-7.28%
Return on Capital Employed (ROCE)	-6.77%
Weighted Average Cost of Capital (WACC)	3.69%
Revenue Per Employee	528,254
Profits Per Employee	-247,096
Employee Count	624
Asset Turnover	0.15
Inventory Turnover	0.57

Taxes

In the past 12 months, DSE:SILVAPHL has paid 12.42 million in taxes.

Income Tax	12.42M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +1.87% in the last 52 weeks. The beta is -0.14, so DSE:SILVAPHL's price volatility has been lower than the market average.

Beta (5Y)	-0.14
52-Week Price Change	+1.87%
50-Day Moving Average	10.53
200-Day Moving Average	10.51
Relative Strength Index (RSI)	56.13
Average Volume (20 Days)	889,676

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, DSE:SILVAPHL had revenue of BDT 329.63 million and -154.19 million in losses. Loss per share was -1.13.

Revenue	329.63M
Gross Profit	85.36M
Operating Income	-141.85M
Pretax Income	-141.76M
Net Income	-154.19M
EBITDA	-88.20M
EBIT	-141.85M
Loss Per Share	-1.13

Balance Sheet

The company has 83.80 million in cash and 2.45 million in debt, with a net cash position of 81.35 million or 0.60 per share.

Cash & Cash Equivalents	83.80M
Total Debt	2.45M
Net Cash	81.35M
Net Cash Per Share	0.60
Equity (Book Value)	2.01B
Book Value Per Share	14.76
Working Capital	712.73M

Cash Flow

In the last 12 months, operating cash flow was -10.36 million and capital expenditures -3.57 million, giving a free cash flow of -13.93 million.

Operating Cash Flow	-10.36M
Capital Expenditures	-3.57M
Depreciation & Amortization	53.64M
Net Borrowing	-39.39M
Free Cash Flow	-13.93M
FCF Per Share	-0.10

Margins

Gross margin is 25.90%, with operating and profit margins of -43.03% and -46.78%.

Gross Margin	25.90%
Operating Margin	-43.03%
Pretax Margin	-43.01%
Profit Margin	-46.78%
EBITDA Margin	-26.76%
EBIT Margin	-43.03%
FCF Margin	n/a

Dividends & Yields

DSE:SILVAPHL does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	-10.36%
FCF Yield	-0.94%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on November 7, 2019. It was a forward split with a ratio of 1.05.

Last Split Date	Nov 7, 2019
Split Type	Forward
Split Ratio	1.05

Scores

Altman Z-Score	n/a
Piotroski F-Score	2